|
ABOUT COMPANY
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders. The company is headquartered in San Diego, California.
|
EARNINGS
Gross Profit (TTM): 0
Market Capitalization: 359881000
Operating Margin (TTM): 0
PE Ratio: None
PEG Ratio: -0.03
Profit Margin: 0
Revenue Per Share (TTM): 0
Revenue (TTM): 0
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -0.706
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: None
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|